dlt446 dlt446

dlt446 dlt446

Clinical Professor

Member of:

  • Neurology


  1. 2023
  2. Published

    Second messenger signalling bypasses CGRP receptor blockade to provoke migraine attacks in humans

    Do, T. P., Deligianni, C., Amirguliyev, S., Snellman, J., Lopez, C. L., Al-Karagholi, M. A. M., Guo, S. & dlt446, dlt446, 2023, In: Brain. 146, 12, p. 5224-5234 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Lack of reproducibility of resting-state functional MRI findings in migraine with aura

    Hougaard, Anders, Gaist, D., Garde, Ellen, Iversen, P., Madsen, C. G., Kyvik, K. O., dlt446, dlt446, Siebner, Hartwig Roman & Madsen, K. H., 2023, In: Cephalalgia : an international journal of headache. 43, 11, 16 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Migraine in older adults

    Hugger, S. S., Do, T. P., Ashina, H., Goicochea, M. T., Jenkins, B., Sacco, S., Lee, M. J., Brennan, K. C., Amin, Faisal Mohammad, Steiner, Timothy & dlt446, dlt446, 2023, In: The Lancet Neurology. 22, 10, p. 934-945 12 p.

    Research output: Contribution to journalReviewResearchpeer-review

  5. Published

    The Registry for Migraine (REFORM) study: methodology, demographics, and baseline clinical characteristics

    Karlsson, W. K., Ashina, H., Cullum, C. K., Christensen, R. H., Al-Khazali, Haidar Muhsen Abdellah, Amin, Faisal Mohammad, dlt446, dlt446 & REFORM Investigators, R. I., 2023, In: Journal of Headache and Pain. 24, 12 p., 70.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Glibenclamide Posttreatment Does Not Inhibit Levcromakalim Induced Headache in Healthy Participants: A Randomized Clinical Trial

    Kokoti, L., Al-Karagholi, M. A. M., Waldorff Nielsen, C. A. & dlt446, dlt446, 2023, In: Neurotherapeutics. 20, 2, p. 389-398 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Design of the contemporary prospective understanding of migraine real-world evidence (CAPTURE) study

    Lanteri-minet, M., Tassorelli, C., dlt446, dlt446, Goadsby, P., Katsarava, Z., Matharu, M., Peres, M., Stark, R., Ailani, J., Leroux, E., Delahaye, L., Ha, H. & Pozo-rosich, P., 2023, In: Journal of the Neurological Sciences. 455, Supplement, p. 214 1 p., 121668.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  8. Published

    Patient-reported migraine-specific quality of life, activity impairment and headache impact with once-daily atogepant for preventive treatment of migraine in a randomized, 52-week trial

    Lipton, R. B., Halker Singh, R. B., Mechtler, L., McVige, J., Ma, J., Yu, S. Y., Stokes, J., Dabruzzo, B., Gandhi, P. & dlt446, dlt446, 2023, In: Cephalalgia. 43, 9, p. 1-10

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030

    Martelletti, P., Leonardi, M., Ashina, M., Burstein, R., Cho, S. J., Charway-Felli, A., Dodick, D. W., Gil-Gouveia, R., Grazzi, L., Lampl, C., MaassenVanDenBrink, A., Minen, M. T., Mitsikostas, D. D., Olesen, J., Owolabi, M. O., Reuter, U., Ruiz de la Torre, E., Sacco, S., Schwedt, T. J., Serafini, G. & 6 others, Surya, N., Tassorelli, C., Wang, S. J., Wang, Y., Wijeratne, T. & Raggi, A., 2023, In: Journal of Headache and Pain. 24, 1, 17 p., 140.

    Research output: Contribution to journalReviewResearchpeer-review

  10. Published

    Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial

    Pozo-Rosich, P., Ailani, J., dlt446, dlt446, Goadsby, P. J., Lipton, R. B., Reuter, U., Guo, H., Schwefel, B., Lu, K., Boinpally, R., Miceli, R., De Abreu Ferreira, R., McCusker, E., Yu, S. Y., Severt, L., Finnegan, M. & Trugman, J. M., 2023, In: The Lancet. 402, 10404, p. 775-785 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Menstrual migraine is caused by estrogen withdrawal: revisiting the evidence

    Raffaelli, B., Do, T. P., Chaudhry, B. A., dlt446, dlt446, Amin, Faisal Mohammad & Ashina, H., 2023, In: Journal of Headache and Pain. 24, 1, 10 p., 131.

    Research output: Contribution to journalReviewResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...38 Next

ID: 920785